Bide Pharmatech's net income growth rate is commendable despite a lower ROE. However, its high payout ratio indicates potential for higher earnings growth with more reinvestment. Future earnings are expected to gain momentum.
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Bide Pharmatech Stock Forum
No comment yet